Trials / Terminated
TerminatedNCT01465581
Treatment of Neurogenic Incontinence by Surgery to Cut the Filum Terminale
A Prospective Trial of Division of the Filum Terminale for Neurogenic Bladder Dysfunction With a Normal Conus
- Status
- Terminated
- Phase
- —
- Study type
- Observational
- Enrollment
- 5 (actual)
- Sponsor
- Nemours Children's Clinic · Academic / Other
- Sex
- All
- Age
- 5 Years – 16 Years
- Healthy volunteers
- Not accepted
Summary
The target population of this study is children with primary or secondary daytime urinary incontinence, who have failed to improve adequately despite compliance with at least 6 months of standard medical therapy. The study hypothesis is that patients who under go cutting the filum terminale - the string-like lower end of the spinal cord - will have improved bladder function at 6-month follow up. Bladder function and its effects on quality of life will be measured before surgery and at 6-month follow up.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Division of the filum terminal | Division of the filum is performed through a 6cm incision over the lumbosacral junction that can be oriented either longitudinally or transversely - to be hidden beneath underclothes or swim wear. A single level laminectomy provides sufficient exposure. The dural opening can be as short as 1cm. Under the microscope the filum is identified visually and separated from lower sacral rootlets with the aid of microelectrode stimulation. When a segment of the filum has been excised and sent for laboratory examination, the dura is closed and reinforced with fibrin glue. The wound is closed in layers, and the patient is kept at bed rest horizontal for 2 nights to discourage CSF fistulization of the wound. |
Timeline
- Start date
- 2011-07-01
- Primary completion
- 2014-04-01
- Completion
- 2014-04-01
- First posted
- 2011-11-07
- Last updated
- 2015-04-17
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01465581. Inclusion in this directory is not an endorsement.